30 years? 50 years? 60 years? While the European Medicines Agency (EMA) voted on Wednesday in favor of adding blood clots to the side effects of the AstraZeneca vaccine, many European countries have decided to allow from a certain age only vaccination with the serum of the Anglo-Swedish firm in order to limit the rare cases of thrombosis noted in recent weeks.
In France, a decision was taken to reserve this vaccine for people over 55 years of age following recommendations from the Haute Autorité de Santé (HAS) which had underlined a “possible increased risk of cerebral venous thrombosis or disseminated intravascular coagulation in people” the youngest. Its administration had also been suspended for a few hours pending an opinion from the European health authorities.
The only problem is that these procrastinations have created a form of mistrust on the part of the French towards the AstraZeneca vaccine, since only 20% of them trust this product. Faced with this state of affairs, many political and scientific personalities assure that to accelerate vaccination, it is now necessary to accept volunteers.
“Zero waste, zero stock”
Invited on the antenna of BFMTV on Tuesday, the president of the regional council of the Île-de-France region Valérie Pécresse believes that in this period of health crisis, “we have to be very pragmatic”. For her, it is important not to waste any dose of the vaccine.
“There are a lot of French people who are ready to be vaccinated with AstraZeneca. There are plenty. If we realize that the priority people are too restrictive and that we stay with doses, we must settle a simple principle, zero waste, zero stock “, she assures us.
Valérie Pécresse believes that it is very important to broaden the eligibility criteria for this vaccine.
“It means opening up the vaccination beyond authorized persons if there are still stocks, vaccines. For example for AstraZeneca say ‘all people over 55 years old, even if they are not fragile, if they are not. ‘have no comorbidities, may be entitled to them.’ Little by little we will move towards collective immunity, but there must be zero waste, “she added.
In her reflection, she is joined by Jean Rottner, president of the Grand Est regional council, who also opts for new vaccination criteria.
“I consider that it is perhaps necessary to open new criteria allowing the vaccination of a different population, of an active population, which fears for its health, which above all agrees to be vaccinated and which has not. no distance from this gesture of care and prevention. If there are still doses of AstraZeneca and we have a voluntary population, we must vaccinate them. We must have a broader and strategic vision in this context -there “, he hammers.
Stop the co-morbidity criteria?
This desire for enlargement is not only specific to the political class. On BFMTV, Robert Sebbag, infectious disease specialist at La Pitié Salpêtrière hospital (AP-HP) in Paris, believes that it would be fashionable to open vaccination to an active population.
“There are people who want to be vaccinated, whatever the vaccine. We must stop these criteria of co-morbidity from the age of 55. Some countries are 50, others are 60, England has Said 30. Those who want to be vaccinated, we explain the risks to them, they are extremely weak. The question is are we going to allow it? “, he explains.
In the field, health professionals believe that before opening the vaccination to all volunteers, it is advisable to take stock of the AstraZeneca product and to insist on the fact that it is not dangerous.
“There is however more chance of dying struck in the street than to have a problem with the vaccine AstraZeneca”, estimates thus in the columns of the Point Jean-Christophe Calmes general practitioner in Frontignan in Hérault and vice-president of the MG France union, who also mentions increasingly heavy educational work.
“It would be interesting to have a communication to put things in perspective. […] A few weeks apart, we had the recommendation to reserve it for young people, then a suspension and finally, we reserved it for the elderly… It is not easy to explain to people, concludes Philippe Besset for his part. , pharmacist and president of the Federation of Pharmaceutical Unions of France (FSPF).
Get the latest news delivered to your inbox
Follow us on social media networks